FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Targeted radiation therapy shows near-complete response in rare sarcoma patients

2.

These Athletes Weren't Doping. Their Genes Made It Look Like They Did.

3.

Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib

4.

Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method

5.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot